Pro-Pro-Thr-Val-Pro-Thr-Arg
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Pro-Pro-Thr-Val-Pro-Thr-Arg
- DrugBank Accession Number
- DB17872
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 766.898
Monoisotopic: 766.433738108 - Chemical Formula
- C34H58N10O10
- Synonyms
- L-arginine, l-prolyl-l-prolyl-l-threonyl-l-valyl-l-prolyl-l-threonyl-
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- CU50CY5QP5
- CAS number
- 1616927-79-7
- InChI Key
- UKUYYHVRVSDDQG-UBXFZUKZSA-N
- InChI
- InChI=1S/C34H58N10O10/c1-17(2)24(40-30(50)26(19(4)46)42-27(47)22-11-7-15-43(22)31(51)20-9-5-13-37-20)32(52)44-16-8-12-23(44)28(48)41-25(18(3)45)29(49)39-21(33(53)54)10-6-14-38-34(35)36/h17-26,37,45-46H,5-16H2,1-4H3,(H,39,49)(H,40,50)(H,41,48)(H,42,47)(H,53,54)(H4,35,36,38)/t18-,19-,20+,21+,22+,23-,24+,25+,26+/m1/s1
- IUPAC Name
- (2S)-5-carbamimidamido-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidin-2-yl]formamido}butanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}butanamido]pentanoic acid
- SMILES
- CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 81367952
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -5.7 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 14 Chemaxon Hydrogen Donor Count 11 Chemaxon Polar Surface Area 308.71 Å2 Chemaxon Rotatable Bond Count 18 Chemaxon Refractivity 201.57 m3·mol-1 Chemaxon Polarizability 78.76 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 01, 2023 20:58 / Updated at June 02, 2023 02:07